HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yue Huang Selected Research

gushudan

1/2018A HILIC-UHPLC-MS/MS untargeted urinary metabonomics combined with quantitative analysis of five polar biomarkers on osteoporosis rats after oral administration of Gushudan.
8/2016An intergated serum and urinary metabonomic research based on UPLC-MS and therapeutic effects of Gushudan on prednisolone-induced osteoporosis rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yue Huang Research Topics

Disease

86Neoplasms (Cancer)
12/2022 - 04/2004
22Inflammation (Inflammations)
01/2022 - 04/2007
19Parkinson Disease (Parkinson's Disease)
10/2019 - 08/2004
17Breast Neoplasms (Breast Cancer)
08/2022 - 01/2014
12Alzheimer Disease (Alzheimer's Disease)
01/2022 - 04/2011
11Carcinogenesis
08/2022 - 04/2010
10Infections
12/2022 - 09/2003
8Neoplasm Metastasis (Metastasis)
06/2022 - 02/2017
8Hepatocellular Carcinoma (Hepatoma)
03/2022 - 08/2014
7Hypoxia (Hypoxemia)
01/2022 - 12/2010
7Type 2 Diabetes Mellitus (MODY)
11/2021 - 09/2018
7Pain (Aches)
01/2020 - 04/2005
6Colorectal Neoplasms (Colorectal Cancer)
10/2021 - 10/2018
6Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 01/2018
6Wounds and Injuries (Trauma)
01/2021 - 04/2005
6Glioma (Gliomas)
01/2021 - 06/2003
6Prostatic Neoplasms (Prostate Cancer)
12/2020 - 01/2014
6Parkinsonian Disorders (Parkinsonism)
01/2018 - 08/2005
5Myopia
11/2022 - 09/2012
5Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 01/2007
5Hypertension (High Blood Pressure)
01/2022 - 09/2012
5Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 01/2008
5Cognitive Dysfunction
01/2022 - 11/2011
5Obesity
11/2021 - 01/2015
5Lung Neoplasms (Lung Cancer)
06/2021 - 08/2016
5Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2021 - 11/2016
5Cardiomegaly (Heart Hypertrophy)
01/2021 - 01/2005
4Congenital Heart Defects (Congenital Heart Defect)
01/2022 - 05/2015
4Dry Eye Syndromes (Dry Eye Syndrome)
01/2022 - 12/2015
4Polyps
03/2021 - 01/2018
4Thalassemia
01/2021 - 05/2011
4Melanoma (Melanoma, Malignant)
08/2020 - 08/2005
4Aneuploidy (Aneuploid)
07/2020 - 01/2019
4Adenocarcinoma
01/2020 - 11/2008
4Stroke (Strokes)
12/2019 - 03/2012
4Dementia (Dementias)
01/2018 - 02/2013
4Osteoporosis
01/2018 - 06/2014
4Fibrosis (Cirrhosis)
09/2017 - 04/2007
4Multiple System Atrophy
12/2008 - 08/2005
3Hemorrhage
07/2022 - 01/2020
3Osteoarthritis
06/2022 - 11/2019
3Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 11/2019
3Body Weight (Weight, Body)
11/2021 - 10/2018
3Ischemia
03/2021 - 04/2005
3Dental Caries (Decay, Dental)
01/2021 - 01/2018

Drug/Important Bio-Agent (IBA)

45Proteins (Proteins, Gene)FDA Link
08/2022 - 06/2003
25Biomarkers (Surrogate Marker)IBA
09/2022 - 11/2008
16Pharmaceutical PreparationsIBA
12/2022 - 10/2005
12Messenger RNA (mRNA)IBA
01/2022 - 06/2003
12EnzymesIBA
01/2022 - 01/2012
11Biological ProductsIBA
12/2022 - 06/2003
10Therapeutic UsesIBA
10/2022 - 02/2004
10DNA (Deoxyribonucleic Acid)IBA
03/2022 - 01/2011
9CateninsIBA
11/2021 - 04/2010
8LipidsIBA
09/2022 - 06/2011
8SynucleinsIBA
03/2016 - 01/2011
7MicroRNAs (MicroRNA)IBA
06/2022 - 11/2012
7VaccinesIBA
03/2022 - 11/2002
7Peptides (Polypeptides)IBA
11/2021 - 06/2011
7Transcription Factors (Transcription Factor)IBA
02/2021 - 04/2010
7Indicators and Reagents (Reagents)IBA
01/2021 - 02/2011
6AntibodiesIBA
12/2022 - 09/2012
6Glucose (Dextrose)FDA LinkGeneric
08/2022 - 03/2012
6RNA (Ribonucleic Acid)IBA
01/2022 - 01/2017
5AntioxidantsIBA
12/2022 - 01/2005
5N-methyladenosineIBA
11/2022 - 01/2015
5CytokinesIBA
01/2022 - 05/2011
5Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 05/2006
5Long Noncoding RNAIBA
10/2021 - 04/2016
5IntegrinsIBA
10/2021 - 08/2005
5CollagenIBA
03/2021 - 12/2010
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2021 - 02/2010
5Liposomes (Liposome)IBA
01/2020 - 08/2005
5Phosphotransferases (Kinase)IBA
04/2019 - 05/2007
5Paclitaxel (Taxol)FDA LinkGeneric
01/2013 - 06/2010
47,3'-dihydroxy-4'-methoxyisoflavoneIBA
01/2022 - 11/2017
4LipopolysaccharidesIBA
01/2022 - 05/2011
4Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 12/2007
46-methyladenineIBA
07/2021 - 01/2017
4ErbB Receptors (EGF Receptor)IBA
06/2021 - 10/2017
4ResveratrolIBA
01/2020 - 01/2005
4Angiotensin IIIBA
04/2019 - 01/2005
4Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
01/2018 - 01/2015
4GlucocorticoidsIBA
09/2017 - 07/2012
4alpha-SynucleinIBA
12/2008 - 02/2006
3Hemoglobins (Hemoglobin)IBA
07/2022 - 05/2011
3Immunoglobulin G (IgG)IBA
03/2022 - 12/2017
3SolutionsIBA
01/2022 - 08/2005
3MicellesIBA
01/2022 - 06/2011
3LigandsIBA
11/2021 - 10/2015
3Protein Kinases (Protein Kinase)IBA
11/2021 - 01/2014
3NF-kappa B (NF-kB)IBA
11/2021 - 04/2007
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2021 - 11/2016

Therapy/Procedure

30Therapeutics
01/2022 - 08/2005
9Immunotherapy
06/2022 - 01/2020
8Drug Therapy (Chemotherapy)
01/2022 - 08/2015
5Transplantation
01/2022 - 09/2012
4Chinese Traditional Medicine (Traditional Chinese Medicine)
08/2020 - 09/2012
3Lasers (Laser)
11/2022 - 08/2013
3Laser In Situ Keratomileusis (LASIK)
11/2022 - 01/2021